Search Results

941 articles with title/keywords/abstract containing Regulatory-process

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
modify search
Display per page 

FDA failing to inform clinicians on benefits/risks

Source: Reactions, Volume 1, Number 1276, 2009-10-31 , pp. 3-3(1)

Publisher: Adis International

US FDA lays out strategy for risk communication

Source: Reactions, Volume 1, Number 1273, 2009-10-10 , pp. 2-2(1)

Publisher: Adis International

Industry improves on-time performance of PMS studies

Source: Reactions, Volume 1, Number 1269, 2009-09-12 , pp. 2-2(1)

Publisher: Adis International

US FDA pushes for mandatory electronic AE reporting

Source: Reactions, Volume 1, Number 1267, 2009-08-29 , pp. 2-2(1)

Publisher: Adis International

US FDA votes for ban or boxed warning on paracetamol combos

Source: Reactions, Volume 1, Number 1260, 2009-07-11 , pp. 2-2(1)

Publisher: Adis International

Pharma required to fund Australian government committee

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 579, 2009-05-30 , pp. 9-9(1)

Publisher: Adis International

Move for more Medicare off-label cancer drugs creates contention

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 572, 2009-02-21 , pp. 2-2(1)

Publisher: Adis International

Move for more Medicare off-label cancer drugs creates contention

Source: Reactions, Volume 1, Number 1241, 2009-02-28 , pp. 1-1(1)

Publisher: Adis International

New trading regulations covering `health foods' helpful

Source: Inpharma, Volume 1, Number 1667, 2008-12-06 , pp. 4-4(1)

Publisher: Adis International

Study targets drugs most in need of research for off-label use

Source: Inpharma, Volume 1, Number 1667, 2008-12-06 , pp. 19-19(1)

Publisher: Adis International

Study targets drugs most in need of research for off-label use

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 568, 2008-12-13 , pp. 8-8(1)

Publisher: Adis International

Researchers say red tape wrecking the rate of rigorous research

Source: Inpharma, Volume 1, Number 1664, 2008-11-15 , pp. 2-2(1)

Publisher: Adis International

A new method for evaluating clinical evidence is needed

Source: Inpharma, Volume 1, Number 1666, 2008-11-29 , pp. 3-3(1)

Publisher: Adis International

One in four biologicals subject to safety actions postapproval

Source: Reactions, Volume 1, Number 1226, 2008-11-01 , pp. 2-2(1)

Publisher: Adis International

One in four biologicals subject to safety actions postapproval

Source: Inpharma, Volume 1, Number 1662, 2008-11-01 , pp. 21-21(1)

Publisher: Adis International

Bayer gets written warning for illegally marketing unapproved drugs

Source: Inpharma, Volume 1, Number 1663, 2008-11-08 , pp. 1-1(1)

Publisher: Adis International

The challenges of foreign clinical data approval in Europe

Source: Inpharma, Volume 1, Number 1659, 2008-10-11 , pp. 4-4(1)

Publisher: Adis International

The European Commission, the EMEA and the US FDA have affirmed their commitment to regulatory cooperation

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 564, 2008-10-18 , pp. 10-10(1)

Publisher: Adis International

Problems with New Zealand's new Eltroxin formulation?

Source: Reactions, Volume 1, Number 1220, 2008-09-20 , pp. 2-2(1)

Publisher: Adis International

Problems with New Zealand's new Eltroxin formulation?

Source: Inpharma, Volume 1, Number 1656, 2008-09-20 , pp. 20-20(1)

Publisher: Adis International

modify search
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A